Vadastuximab talirine(SGN-CD33A)是一种靶向CD33的新型抗体偶联药物,由吡咯苯二氮平类二聚类化合物组成;CD33,在大部分急性粒细胞白血病(AML)患者中表达。 货号(Catalog No.) CSD00386 通用名INN Vadastuximab Talirine 纯度(Purity) >95% 浓度( Concentration) ...
Vadastuximab talirine, also known as SGN-CD33A, is an antibody-drug conjugate or ADC for the treatment of front-line acute myeloid leukemia (AML) patients.
S., Ho, P. A. & Erba, H. P. SGN-CD33A (vadastuximab talirine) followed by allogeneic hematopoietic stem cell transplant (alloHSCT) results in durable complete remissions (CRs) in patients with acute myeloid leukemia (AML). Biol. Blood Marrow Transplant. 22, S211-S212 (2016)....